Rituximab induced heart failure in B-cell Non-Hodgkin lymphoma: an unprecedented lethal adverse drug reaction
preprint
OA: closed
Abstract
The vast clinical applicability of rituximab mandates a complete understanding of its adverse effect profile. We report a case of non-hodgkin's lymphoma on rituximab therapy progressing to heart failure. Patients undergoing chemotherapy have multiple comorbidities and thus astute drug selection and monitoring is imperative.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00